Setlur and colleagues identified a subtype of prostate cancer characterized by the fusion of the 5′-untranslated region of the androgen-regulated transmembrane protease serine 2 (TMPRSS2) promoter with erythroblast transformation-specific transcription factor family members (TMPRSS2-ER). The gene discussed is TMPRSS2; the disease is prostate carcinoma.